Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jane Messina MD

Jane L. Messina MD

Vice Chair, Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; Professor of Oncologic Sciences, Pathology and Cell Biology, and Dermatology, University of South Florida Morsani College of Medicine, Tampa, Florida

After completing residency in anatomic and clinical pathology and a fellowship in dermatopathology, Dr. Messina joined the faculty in the Department of Pathology and Cell Biology at the University of South Florida Morsani College of Medicine in Tampa in 1994, where she practiced for 20 years before moving to Moffitt Cancer Center.

She is currently Vice Chair of the Department of Anatomic Pathology at Moffitt, Senior Member in the Departments of Anatomic Pathology and Cutaneous Oncology at Moffitt, section head of Dermatopathology and Professor of Oncologic Sciences, Pathology and Cell Biology, and Dermatology at USF.

Her passions include teaching and mentoring of pathology and dermatology residents, as well as 14 dermatopathology fellows to date, and practicing within the busy diagnostic service at Moffitt, which treats >2,000 new melanoma patients annually.

She has been director of the dermatopathology fellowship at USF since 2011. She was a leader of the pathology core of the Moffitt Skin SPORE grant. Her research interests include pathology of the sentinel node, biomarkers of prognosis in cutaneous melanoma, and etiology and treatment of Merkel cell carcinoma, and she has published over 250 papers in peer-reviewed journals.

Disclosures

No disclosures reported.